Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188875 · ClinicalTrials.gov registry record · NA
Fitbit One and Text Messaging Prompts to Promote Physical Activity in Overweight/Obese Adults
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02188875 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 67 participants.
The verdict
NCT02188875, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
Previous studies suggest self-regulatory techniques including self-monitoring, and SMS text-messaging as an intervention modality, can modify health behaviors including physical activity (PA). The primary purpose of this study was to examine change in objectively measured PA in a randomized controlled pilot trial that tested a wearable sensor/device (Fitbit One) for self-monitoring and SMS text-messaging prompts to promote PA in overweight/obese adults. In a 2-group design, 67 participants were provided the Fitbit One and half were randomized to receive 3 daily SMS-based PA prompts. A Fitbit One was provided to facilitate self-monitoring with a wearable tracker for instant feedback and website of daily PA summaries. Outcome measures were number of steps and minutes of PA by intensity-level using two accelerometers: Actigraph GT3X+ (primary) at baseline and 6-week follow-up and Fitbit One (secondary) at baseline and weeks 1-6. The main hypothesis was that text messaging plus the Fitbit One would show a greater increase in steps and minutes of PA compared to only the Fitbit One at 6-week follow-up.
Interventions
- BEHAVIORAL SMS Text Messages & Fitbit One
- BEHAVIORAL Fitbit One Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02188875
The ClinicalTrials.gov registry entry for NCT02188875 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SMS Text Messages & Fitbit One is the first listed.
NCT02188875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02188875 about?
NCT02188875 is a clinical study titled "Fitbit One and Text Messaging Prompts to Promote Physical Activity in Overweight/Obese Adults". Previous studies suggest self-regulatory techniques including self-monitoring, and SMS text-messaging as an intervention modality, can modify health behaviors including physical activity (PA). The primary purpose of this study was to examine change in objectively measured PA in a randomized controll...
What is the current status of trial NCT02188875?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2013-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02188875?
The interventions under investigation include: SMS Text Messages & Fitbit One (BEHAVIORAL), Fitbit One Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT02188875?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.